CSST1_CONAE
ID CSST1_CONAE Reviewed; 82 AA.
AC P0DW23;
DT 03-AUG-2022, integrated into UniProtKB/Swiss-Prot.
DT 03-AUG-2022, sequence version 1.
DT 03-AUG-2022, entry version 1.
DE RecName: Full=Consomatin Ar1 {ECO:0000303|PubMed:35383850};
DE Short=ConSST Ar1 {ECO:0000305};
DE AltName: Full=Somatostatin-related peptide {ECO:0000303|PubMed:35383850};
DE Short=SSRP {ECO:0000303|PubMed:35383850};
DE Flags: Precursor;
OS Conus arenatus (Sand-dusted cone).
OC Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
OC Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus.
OX NCBI_TaxID=89451;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Venom duct;
RX PubMed=35383850; DOI=10.1093/molbev/msac075;
RA Koch T.L., Ramiro I.B.L., Florez-Salcedo P., Engholm E., Jensen K.J.,
RA Chase K., Olivera B.M., Bjoern-Yoshimoto W.E., Safavi-Hemami H.;
RT "Reconstructing the origins of the somatostatin and allatostatin-C
RT signaling systems using the accelerated evolution of biodiverse cone snail
RT venoms.";
RL Mol. Biol. Evol. 0:0-0(2022).
CC -!- FUNCTION: Moderately activates human somatostatin receptors (SSTR) with
CC a preferential activation of SSTR1 and SSTR4. In vivo, does not cause
CC behavioral changes in mice within a few minutes of intracranial
CC injection, but causes a progressive loss of movement thereafter. Four
CC to five hours after injection, mice recover, even with the highest dose
CC tested. Shows antinociception and antihyperalgesia activities in two
CC mouse models of acute pain, most probably by acting outside the central
CC nervous system. {ECO:0000250|UniProtKB:P0DQT5}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305|PubMed:35383850}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom duct.
CC {ECO:0000305|PubMed:35383850}.
CC -!- DOMAIN: The cysteine framework is C-C. {ECO:0000305}.
CC -!- MISCELLANEOUS: This peptide is an evolutionarily optimized stable
CC analog of somatostatin. In addition, it adopts nearly identical
CC conformations as in the somatostatin drug analog Octreotide. As this
CC drug, it contains a D-Trp at the same position, whose synthesis is a
CC common strategy used for enhancing the metabolic stability of compounds
CC in drug design. {ECO:0000250|UniProtKB:P0DQT5}.
CC -!- MISCELLANEOUS: Consomatins evolved by gene duplication of a
CC 'Somatostatin and related peptides (SSRP)' gene expressed in the snail
CC neuroendocrine system. {ECO:0000269|PubMed:35383850}.
CC -!- MISCELLANEOUS: Does not activate any of the other 313 GPCRs tested.
CC Shows little or no activating activity at the SSTR2, SSTR3 and SSTR5.
CC {ECO:0000250|UniProtKB:P0DQT5}.
CC -!- SIMILARITY: Belongs to the conotoxin C superfamily. Consomatin family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
PE 3: Inferred from homology;
KW D-amino acid; Disulfide bond; G-protein coupled receptor impairing toxin;
KW Hydroxylation; Secreted; Signal; Toxin.
FT SIGNAL 1..22
FT /evidence="ECO:0000255"
FT PROPEP 23..60
FT /evidence="ECO:0000305|PubMed:35383850"
FT /id="PRO_0000456128"
FT PEPTIDE 61..73
FT /note="Consomatin Ar1"
FT /evidence="ECO:0000305|PubMed:35383850"
FT /id="PRO_0000456129"
FT PROPEP 74..82
FT /evidence="ECO:0000305|PubMed:35383850"
FT /id="PRO_0000456130"
FT MOD_RES 66
FT /note="D-tryptophan"
FT /evidence="ECO:0000250|UniProtKB:P0DQT5"
FT MOD_RES 70
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000305"
FT MOD_RES 71
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000305"
FT MOD_RES 73
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000305"
FT DISULFID 64..69
FT /evidence="ECO:0000250|UniProtKB:P0DQT5"
SQ SEQUENCE 82 AA; 9491 MW; BFCAE3AF21FC9DEB CRC64;
MQTAYWVVVM MMMVWVTAPV SEGGKLSDVI WGLVPDDLTP QIILQILNAS RHAYRRVRPR
GQICIWKVCP PLPQWIHPLV KR